# FDA Inspection 1160122 - Shelly D Senders MD - December 17, 2021

Source: https://www.keypedia.com/records/fda_inspections/shelly-d-senders-md/b9f508ad-62ae-40d5-b2d1-4f915598be08
Source feed: FDA_Inspections

> FDA Inspection 1160122 for Shelly D Senders MD on December 17, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1160122
- Company Name: Shelly D Senders MD
- Inspection Date: 2021-12-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 863529 - 2014-01-23](https://www.keypedia.com/records/fda_inspections/shelly-d-senders-md/ef76f7b1-cb56-49f0-960c-102b4bdddeee)
- [FDA Inspection 790940 - 2012-07-17](https://www.keypedia.com/records/fda_inspections/shelly-d-senders-md/915f7d06-21bc-404e-beaf-205084366e10)

Company: https://www.keypedia.com/companies/shelly-d-senders-md/ad039fa3-4036-4192-b9b3-bb6e0d4589cb

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d